Persistence of west Nile virus in the central nervous system and periphery of mice

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Appler, Kim K ^a   Brown, Ashley N ^a,b,c   Stewart, Barbara S ^a,b   Behr, Melissa J ^a,b,d   Demarest, Valerie L ^a   Wong, Susan J ^a,b   Bernard, Kristen A ^a,b,d  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c ORDWAY RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; VIRUS ANTIBODY; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; C57BL 6 MOUSE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; TISSUE DISTRIBUTION; VIRUS ENCEPHALITIS; VIRUS REACTIVATION; VIRUS REPLICATION; WEST NILE FEVER; WEST NILE FLAVIVIRUS; ANIMAL; ANTIBODY PRODUCTION; DRUG EFFECT; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; LONGEVITY; PATHOLOGY; PHYSIOLOGY; RECURRENT DISEASE; VIROLOGY;

ANIMALIA; MUS; RNA VIRUSES; WEST NILE VIRUS;

ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; CENTRAL NERVOUS SYSTEM; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSION; LONGEVITY; MICE; ORGAN SPECIFICITY; RECURRENCE; RNA, VIRAL; WEST NILE FEVER; WEST NILE VIRUS;

EID: 77956285273     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010649     Document Type: Article

References (48)

1. Briese T, Jia XY, Huang C, Grady LJ, Lipkin WI (1999) Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis [published erratum appears in Lancet 1999 Nov 6;354(9190):1650]. Lancet 354: 1261-1262.
2. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, et al. (1999) Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286: 2333-2337.
3. Mostashari F, Bunning ML, Kitsutani PT, Singer DA, Nash D, et al. (2001) Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358: 261-264.
4. Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, et al. (2006) West Nile virus infections projected from blood donor screening data, United States, 2003. Emerg Infect Dis 12: 395-402.
5. Petersen LR, Hayes EB (2008) West Nile virus in the Americas. Med Clin North Am 92: 1307-1322, ix.
6. Cao NJ, Ranganathan C, Kupsky WJ, Li J (2005) Recovery and prognosticators of paralysis in West Nile virus infection. J Neurol Sci 236: 73-80.
7. Carson PJ, Konewko P, Wold KS, Mariani P, Goli S, et al. (2006) Long-term clinical and neuropsychological outcomes of West Nile virus infection. Clin Infect Dis 43: 723-730.
8. Gottfried K, Quinn R, Jones T (2005) Clinical description and follow-up investigation of human West Nile virus cases. South Med J 98: 603-606.
9. Haaland KY, Sadek J, Pergam S, Echevarria LA, Davis LE, et al. (2006) Mental status after West Nile virus infection. Emerg Infect Dis 12: 1260-1262.
10. Klee AL, Maidin B, Edwin B, Poshni I, Mostashari F, et al. (2004) Long-term prognosis for clinical West Nile virus infection. Emerg Infect Dis 10: 1405-1411.
11. Loeb M, Hanna S, Nicolle L, Eyles J, Elliott S, et al. (2008) Prognosis after West Nile virus infection. Ann Intern Med 149: 232-241.
12. Ou AC, Ratard RC (2005) One-year sequelae in patients with West Nile virus encephalitis and meningitis in Louisiana. J La State Med Soc 157: 42-46.
13. Patnaik JL, Harmon H, Vogt RL (2006) Follow-up of 2003 human West Nile virus infections, Denver, Colorado. Emerg Infect Dis 12: 1129-1131.
14. Sadek JR, Pergam SA, Harrington JA, Echevarria LA, Davis LE, et al. (2010) Persistent neuropsychological impairment associated with West Nile virus infection. J Clin Exp Neuropsychol 32: 81-87.
15. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, et al. (2003) Neurologic manifestations and outcome of West Nile virus infection. JAMA 290: 511-515.
16. Sejvar JJ, Bode AV, Marfin AA, Campbell GL, Pape J, et al. (2006) West Nile virus-associated flaccid paralysis outcome. Emerg Infect Dis 12: 514-516.
17. Sejvar JJ, Curns AT, Welburg L, Jones JF, Lundgren LM, et al. (2008) Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol 2: 477-499.
18. Watson JT, Pertel PE, Jones RC, Siston AM, Paul WS, et al. (2004) Clinical characteristics and functional outcomes of West Nile fever. Ann Intern Med 141: 360-365.
19. Murray K, Walker C, Herrington E, Lewis JA, McCormick J, et al. (2010) Persistent infection with West Nile virus years after initial infection. J Infect Dis 201: 2-4.
20. Busch MP, Kleinman SH, Tobler LH, Kamel HT, Norris PJ, et al. (2008) Virus and antibody dynamics in acute West Nile virus infection. J Infect Dis 198: 984-993.
21. Prince HE, Tobler LH, Lape-Nixon M, Foster GA, Stramer SL, et al. (2005) Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors. J Clin Microbiol 43: 4316-4320.
22. Prince HE, Tobler LH, Yeh C, Gefter N, Custer B, et al. (2007) Persistence of West Nile virus-specific antibodies in viremic blood donors. Clin Vaccine Immunol 14: 1228-1230.
23. Roehrig JT, Nash D, Maldin B, Labowitz A, Martin DA, et al. (2003) Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 9: 376-379.
24. Kapoor H, Signs K, Somsel P, Downes FP, Clark PA, et al. (2004) Persistence of West Nile Virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virol 31: 289-291.
25. Burke DS, Nisalak A, Ussery MA, Laorakpongse T, Chantavibul S (1985) Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis 151: 1093-1099.
26. Ravi V, Desai AS, Shenoy PK, Satishchandra P, Chandramuki A, et al. (1993) Persistence of Japanese encephalitis virus in the human nervous system. J Med Virol 40: 326-329.
27. Kuno G (2001) Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts. Reviews in Medical Virology 11: 165-190.
28. Pogodina VV, Frolova MP, Malenko GV, Fokina GI, Koreshkova GV, et al. (1983) Study on West Nile virus persistence in monkeys. Arch Virol 75: 71-86.
29. Tonry JH, Xiao SY, Siirin M, Chen H, da Rosa AP, et al. (2005) Persistent shedding of West Nile virus in urine of experimentally infected hamsters. Am J Trop Med Hyg 72: 320-324.
30. Nemeth N, Young G, Ndaluka C, Bielefeldt-Ohmann H, Komar N, et al. (2009) Persistent West Nile virus infection in the house sparrow (Passer domesticus). Arch Virol 154: 783-789.
31. Brown AN, Kent KA, Bennett CJ, Bernard KA (2007) Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates. Virology 368: 422-430.
32. Ostlund EN, Crom RL, Pedersen DD, Johnson DJ, Williams WO, et al. (2001) Equine West Nile encephalitis, United States. Emerg Infect Dis 7: 665-669.
33. Nemeth NM, Oesterle PT, Bowen RA (2009) Humoral immunity to West Nile virus is long-lasting and protective in the house sparrow (Passer domesticus). Am J Trop Med Hyg 80: 864-869.
34. Wong SJ, Demarest VL, Boyle RH, Wang T, Ledizet M, et al. (2004) Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay. J Clin Microbiol 42: 65-72.
35. Halford WP, Schaffer PA (2000) Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants to establish wild-type levels of latency in vivo. J Virol 74: 5957-5967.
36. Xiao SY, Guzman H, Zhang H, Travassos da Rosa AP, Tesh RB (2001) West Nile virus infection in the golden hamster (Mesocricetus auratus): a model of West Nile encephalitis. Emerg Infect Dis 7: 714-721.
37. Tesh RB, Siirin M, Guzman H, Travassos da Rosa AP, Wu X, et al. (2005) Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections. J Infect Dis 192: 287-295.
38. Reisen WK, Fang Y, Lothrop HD, Martinez VM, Wilson J, et al. (2006) Overwintering of West Nile Virus in Southern California. J Med Entomol 43: 344-355.
39. Custer B, Kamel H, Kiely NE, Murphy EL, Busch MP (2009) Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening. Transfusion (Paris) 49: 278-288.
40. Mathur A, Arora KL, Rawat S, Chaturvedi UC (1986) Persistence, latency and reactivation of Japanese encephalitis virus infection in mice. J Gen Virol 67: 381-385.
41. Binder GK, Griffin DE (2001) Interferon-gamma-mediated site-specific clearance of alphavirus from CNS neurons. Science 293: 303-306.
42. DeSalvo D, Roy-Chaudhury P, Peddi R, Merchen T, Konijetti K, et al. (2004) West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death. Transplantation 77: 466-469.
43. Shi PY, Tilgner M, Lo MK, Kent KA, Bernard KA (2002) Infectious cDNA clone of the epidemic West Nile virus from New York City. J Virol 76: 5847-5856.
44. Lim PY, Louie KL, Styer LM, Shi PY, Bernard KA (2010) Viral pathogenesis in mice is similar for West Nile virus derived from mosquito and mammalian cells. Virology 400: 93-103.
45. Kauffman EB, Jones SA, Dupuis AP, Ngo KA, Bernard KA, et al. (2003) Virus detection protocols for West Nile virus in vertebrate and mosquito specimens. J Clin Microbiol 41: 3661-3667.
46. Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, et al. (2000) Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 38: 4066-4071.
47. Wong SJ, Boyle RH, Demarest VL, Woodmansee AN, Kramer LD, et al. (2003) Immunoassay targeting nonstructural protein 5 to differentiate West Nile virus infection from dengue and St. Louis encephalitis virus infections and from flavivirus vaccination. J Clin Microbiol 41: 4217-4223.
48. Pearce BD, Hobbs MV, McGraw TS, Buchmeier MJ (1994) Cytokine induction during T-cell-mediated clearance of mouse hepatitis virus from neurons in vivo. J Virol 68: 5483-5495.